Evidence map›Paper›PMID 41020504›Full record

ArticleNucleic acids research2025

Structural and evolutionary determinants of Argonaute function.

Arndt Wallmann, Mathew Van de Pette

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Germline fate determination by a single ARGONAUTE protein inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arndt WallmannMRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, United Kingdom.ORCID 0000-0002-7003-5079
Mathew Van de PetteMRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, United Kingdom.ORCID 0000-0002-1423-5957

Funding

MRC RG94521UK Health Security Agency
6 · The paper itself

Abstract

Members of the Argonaute protein superfamily adopt functions ranging from host-defense to mediating elaborate and multicomponent post-transcriptional and epigenetic systems of control. Despite this diversity of biological roles, the Argonaute structural fold is highly conserved throughout all domains of life. This raises questions about how Argonautes evolved to adapt to this increasing complexity of function, while conserving features that are broadly shared across the phylogenetic tree. Integrating structural, sequence, phylogenetic data, and disease-related mutational data, we compiled a comprehensive study of the Argonaute evolutionary trajectory. By comparing Argonaute proteins across a diverse set of lineages and extensive evolutionary timescale, we identified universal and clade-specific sequence signatures and intra-protein contact networks that underlie the Argonaute structural fold, nucleic acid interface and protein-protein binding sites. We analyze how these features are affected by disease-related mutations and are fundamentally altered in the case of the Argonaute-like Med13 protein. With this work we gain better insights into how Argonaute function diversified in eAgos by tracing the emergence of conserved molecular features that are associated with new biological functions.

Indexed as

Argonaute ProteinsEvolution, MolecularAnimalsBinding SitesHumansModels, MolecularMutationPhylogenyProtein BindingArgonaute Proteins

Identifiers

PMID41020504
PMCPMC12477606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.